Skip Navigation Archive: U.S. Department of Health and Human Services U.S. Department of Health and Human Services
Archive: Agency for Healthcare Research Quality
Archival print banner

This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: Let us know the nature of the problem, the Web address of what you want, and your contact information.

Please go to for current information.

Mortality Measurement: Development of the 3M™ All Patient Refined Diag

Presentations from a November 2008 meeting to discuss issues related to mortality measures.

Table 2-4. Categories of Secondary Diagnoses for MDC 15

MDC 15 Secondary Diagnosis Category

No.Secondary Diagnosis
900Craniofacial Anomalies
901Musculoskeletal Anomalies
902Maternal Infections & Other Maternal Effects Except Noxious Substances
903Chromosomal Anomaly NOS
904Perinatal Jaundice from Prematurity/Other Specified Causes
905Circulatory Disorder Diagnoses
906Gastrointestinal Disorder Diagnoses
907Newborn Peripheral Nerve Injury
908Fetal Malnutrition
909Newborn Meconium Aspiration
910Other Newborn Respiratory Problem/Other Asphyxia
911Newborn Feeding Problem Diagnoses
912Hypo-Hypertonia/Other Newborn Problem Diagnoses
913Noxious Influences Affecting Fetus Through Placenta/Breast Milk
914Infant of Diabetic Mother
915Hemolytic Disease Due to Isoimmunization
916Other Hematologic Disorders Except Isoimmunization
920Transient Tachypnea

Return to Document


Page last reviewed March 2009
Internet Citation: Mortality Measurement: Development of the 3M™ All Patient Refined Diag. March 2009. Agency for Healthcare Research and Quality, Rockville, MD.


The information on this page is archived and provided for reference purposes only.


AHRQ Advancing Excellence in Health Care